Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | BCHE | P06276 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31465578 | 1.00 | LMNA (0.54) | LMNATRPA1PTGS1CACNA1CACHE | |
| Acetonitrile SCHEMBL6322318 | 0.91 | ACHE (0.48) | LMNATRPA1PTGS1CACNA1CACHE | |
| SCHEMBL3926186 | 0.84 | LMNA (0.56) | LMNATRPA1PTGS1CACNA1CACHE | |
| SCHEMBL16953409 | 0.83 | ACHE (0.37) | LMNAACHEBCHEMEN1KMT2A | |
| SCHEMBL10361169 | 0.83 | ACHE (0.40) | ACHE | |
| SCHEMBL19122398 | 0.83 | ACHE (0.37) | LMNAACHEBCHEMEN1KMT2A | |
| SCHEMBL801219 | 0.83 | HDAC4 (0.48) | LMNATRPA1PTGS1CACNA1CACHE | |
| SCHEMBL84033 | 0.82 | PPARG (0.53) | LMNAACHEKMT2AHDAC4HDAC8 | |
| SCHEMBL12909064 | 0.82 | ALDH1A1 (0.47) | LMNAACHEBCHESMN1; SMN2ALDH1A1 | |
| SCHEMBL12160695 | 0.81 | LMNA (0.52) | LMNATRPA1PTGS1CACNA1CACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687452-A1 | ESSENTIAL OIL IMPREGNATED DEVICE AND METHODS OF USE THEREOF | Pertinent Eco-Solutions Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024206844-A1 | ESSENTIAL OIL IMPREGNATED DEVICE AND METHODS OF USE THEREOF | PERTINENT ECO-SOLUTIONS, INC. (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240324605-A1 | ESSENTIAL OIL IMPREGNATED DEVICE AND METHODS OF USE THEREOF | PERTINENT ECO SOLUTIONS INC (US) | 2024-10-03 | — | — | US | claimed |
| EP-4426120-A1 | COMPOSITIONS AND METHODS OF CONTROLLING PESTS | Pertinent Eco-Solutions Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| CN-117204445-A | Use of musk volatile from Menghuamao, insect-resistant agent and method for controlling agricultural insect | 中国科学院昆明植物研究所 | 2023-12-12 | — | — | CN | claimed |
| CN-116585388-A | Application of Menghua musk extract and anti-allergic agent | 中国科学院昆明植物研究所 | 2023-08-15 | — | — | CN | claimed |
| US-20230149514-A1 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | UNIVERSITY OF MASSACHUSETTS | 2023-05-18 | — | — | US | claimed |
| US-20230137223-A1 | COMPOSITIONS AND METHODS OF CONTROLLING PESTS | PERTINENT ANIMAL HEALTH, INC. (US) | 2023-05-04 | — | — | US | claimed |
| WO-2023076685-A1 | COMPOSITIONS AND METHODS OF CONTROLLING PESTS | PERTINENT ECO-SOLUTIONS INC. (US) | 2023-05-04 | — | — | WO | claimed |
| CN-114631546-B | Application of fleabane extract and herbicide | 中国科学院昆明植物研究所 | 2022-08-26 | — | — | CN | claimed |
| US-20200306347-A1 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | THE UNIVERSITY OF MASSACHUSETTS | 2020-10-01 | — | — | US | claimed |
| WO-2019118444-A1 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | THE UNIVERSITY OF MASSACHUSETTS (US) | 2019-06-20 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2919773-A1 | METHODS OF TREATMENT OF KERATINOCYTE-DERIVED LESIONS | The Trustees of Columbia University in the City of New York (US) | 2015-09-23 | — | — | EP | claimed |
| WO-2014078868-A1 | METHODS OF TREATMENT OF KERATINOCYTE-DERIVED LESIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-05-22 | — | — | WO | claimed |
| CN-103153272-A | Compositions comprising derivatives of essential oil compounds and use in personal care products | PROCTER & GAMBLE | 2013-06-12 | — | — | CN | claimed |
| EP-2595642-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | The Procter and Gamble Company (US) | 2013-05-29 | — | — | EP | claimed |
| WO-2012012385-A2 | COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-26 | — | — | WO | claimed |
| US-20120014883-A1 | Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products | THE PROCTER & GAMBLE COMPANY | 2012-01-19 | — | — | US | claimed |
| WO-2009006921-A1 | MICROPOROUS MATERIAL FOR SURGICAL IMPLANT | BOUZA BARRERA JOSE (ES) | 2009-01-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200306347-A1 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | COL1A1, COL14A1, COL2A1 | LMNA 176/4885TRPA1 4127/4885PTGS1 328/4885 |
| US-20230149514-A1 | CROSSLINKED PARTICLES, COMPOSITION COMPRISING THE CROSSLINKED PARTICLES, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD OF TREATING AN INFECTION | COL1A1, COL14A1, COL2A1 | LMNA 176/4885TRPA1 4127/4885PTGS1 328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.